Adrienne Cobb, MD, MS

Publications

• Does Neoadjuvant Chemotherapy in Clinical T1-T2 N0 Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery?

  (Cortina CS, Lloren JI, Rogers C, Johnson MK, Cobb AN, Huang CC, Kong AL, Singh P, Teshome M.) Ann Surg Oncol. 2024 May;31(5):3128-3140 PMID: 38270828 PMCID: PMC11003830 SCOPUS ID: 2-s2.0-85183006469 01/25/2024

• ASO Visual Abstract: Does Neoadjuvant Chemotherapy in Clinical T1-T2 N0 Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery?

  (Cortina CS, Lloren JI, Rogers C, Johnson MK, Cobb AN, Huang CC, Kong AL, Singh P, Teshome M.) Ann Surg Oncol. 2024 Feb 15 PMID: 38358610 SCOPUS ID: 2-s2.0-85183006469 02/15/2024

• Breast Cancer Subtypes: Clinicopathologic Features and Treatment Considerations

  (Cobb AN, Czaja R, Jorns J, Cortina CS.) Current Breast Cancer Reports. 2024 SCOPUS ID: 2-s2.0-85188604136 01/01/2024

• Retraction Notice to Carotid Body Tumor Resection: Just as Safe without Preoperative Embolization [Annals of Vascular Surgery 46 (2018) 54-59].

  (Cobb AN, Barkat A, Daungjaiboon W, Halandras P, Crisostomo P, Kuo PC, Aulivola B.) Ann Vasc Surg. 2024 Jan;98:406 PMID: 38071033 SCOPUS ID: 2-s2.0-85179648015 12/10/2023

• National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial.

  (Rogers C, Cobb AN, Lloren JIC, Chaudhary LN, Johnson MK, Huang CC, Teshome M, Kong AL, Singh P, Cortina CS.) Breast Cancer Res Treat. 2024 Jan;203(2):317-328 PMID: 37864105 PMCID: PMC10872271 SCOPUS ID: 2-s2.0-85174540456 10/21/2023

• ASO Visual Abstract: Assessing the Complex General Surgical Oncology Pipeline-Trends in Race and Ethnicity Among US Medical Students, General Surgery Residents, and Complex General Surgical Oncology Trainees.

  (Collins RA, Sheriff SA, Yoon C, Cobb AN, Kothari AN, Newman LA, Dossett LA, Willis AI, Wong SL, Clarke CN.) Ann Surg Oncol. 2023 Aug;30(8):4587-4588 PMID: 37191861 SCOPUS ID: 2-s2.0-85164243995 05/16/2023

• Assessing the Complex General Surgical Oncology Pipeline: Trends in Race and Ethnicity Among US Medical Students, General Surgery Residents, and Complex General Surgical Oncology Trainees.

  (Collins RA, Sheriff SA, Yoon C, Cobb AN, Kothari AN, Newman LA, Dossett LA, Willis AI, Wong SL, Clarke CN.) Ann Surg Oncol. 2023 Aug;30(8):4579-4586 PMID: 37079205 SCOPUS ID: 2-s2.0-85153059305 04/20/2023

• Invited Commentary: Current and Future Opportunities in Mitigating Breast Cancer Disparity.

  (Cortina CS, Cobb AN, Kong AL.) J Am Coll Surg. 2023 Jun 01;236(6):1239-1241 PMID: 37058342 SCOPUS ID: 2-s2.0-85159732449 04/15/2023

• Risk Factors for Breast Cancer-Related Lymphedema, Risk Reduction, and Myths about Precautionary Behaviors

  (Cobb A, DeSnyder SM.) Current Breast Cancer Reports. March 2023;15(1):1-11 SCOPUS ID: 2-s2.0-85146661873 03/01/2023

• ASO Visual Abstract: Long-Term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement.

  (Cobb AN, Diao K, Teshome M, Lucci A, Ueno NT, Stauder M, Layman RM, Kuerer HM, Woodward WA, Sun SX.) Ann Surg Oncol. 2022 Dec;29(Suppl 3):620-621 PMID: 36104531 SCOPUS ID: 2-s2.0-85142403643 09/15/2022

• ASO Author Reflections: Inflammatory Breast Cancer with Supraclavicular Nodal Involvement-Favorable Long-Term Outcomes can be Achieved.

  (Cobb AN, Sun SX.) Ann Surg Oncol. 2022 Oct;29(10):6393-6394 PMID: 35842535 SCOPUS ID: 2-s2.0-85134464473 07/17/2022

• Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement.

  (Cobb AN, Diao K, Teshome M, Lucci A, Ueno NT, Stauder M, Layman RM, Kuerer HM, Woodward WA, Sun SX.) Ann Surg Oncol. 2022 Oct;29(10):6381-6392 PMID: 35834145 SCOPUS ID: 2-s2.0-85134313332 07/15/2022